Abstract:
PURPOSE: An anticholesterol composition is provided to suppress the activities of HMG-CoA reductase and acyl-CoA:cholesterol acyltransferase (ACAT) and to lower cholesterol in serum using a Lycii radicis cortex-derived tyramine derivative, thereby preventing hyperlipidemia. CONSTITUTION: A method for preparing an anticholesterol tyramine derivative comprises the steps of: extracting Lycii radicis cortex powder with an ethanol solution and filtering the extract; concentrating the extract by compression; and performing Sep-Pak C18 cartridges column chromatography. The derivative is trans-N-p-coumaroyltyramine (CT) or trans-N-feruloyltyramine (FT). A functional food composition for anticholesterol and antioxidative effects contains the tyramine derivative as an active ingredient.
Abstract:
PURPOSE: An energy harvesting apparatus is provided to widen the frequency band of an electric output by changing vibrating energy into electric energy. CONSTITUTION: An energy harvesting apparatus includes a cantilever (110), a movable mass (140), an elastic member (130), and an electric energy generator (150). One end of the cantilever is fixed to a structure (1). The cantilever generates a vibration dislocation by receiving a vibration from the structure. The movable mass is arranged on the other end of the cantilever and moves in the length direction of the cantilever. The elastic member fixes the movable mass to move on the cantilever. The electric energy generator is arranged on the cantilever and changes the vibrating energy of the cantilever to electric energy by being deformed when the cantilever generates the vibration dislocation. [Reference numerals] (AA) Vibration
Abstract:
본 발명에 따른 뇌파신호를 이용한 사용자 맞춤형 경혈 자극방법은 감정제어모드, 집중력향상모드 또는 건강관리모드 중 어느 하나의 운전모드를 사용자로부터 입력받는 제1단계, 사용자의 손에 대해 미리 정해진 복수의 경혈점 중 상기 입력된 운전모드에서 자극할 경혈점인 제어경혈점을 설정하는 제2단계, 및 상기 입력된 운전모드에 대해 미리 저장된 방식으로 사용자의 뇌파를 측정하여 현재 사용자의 뇌파상태를 판단하고, 판단결과에 따라 상기 제어경혈점을 자극하는 제3단계를 포함하는 것을 특징으로 한다. 본 발명에 따른 뇌파신호를 이용한 사용자 맞춤형 경혈 자극방법은 상기 측정한 사용자 뇌파의 분석결과 건강상태에 이상이 있다고 판단되는 경우에는 장갑형태로 구성된 경혈 자극부에 의해 사용자의 현재 뇌파상태와 자극에 대한 사용자 고유의 뇌파 반응특성을 고려하여 설정된 제어경혈점을 자극하여 사용자의 뇌파상태를 정상상태로 유도하는 방식이기 때문에, 다수인에 대해 통계적으로 정해진 자극점을 자극하는 종래 기술과 대비할 때 사용자의 뇌파상태를 현저히 효과적으로 정상상태로 유도할 수 있다는 장점이 있다.
Abstract:
PURPOSE: A production method of a mulberry leaf extract is provided to mass-produce refined powder containing flavonoid with the high value from mulberry leaves. CONSTITUTION: Mulberry leaves harvested in June are pre-dried in the shade for a week, and dried in a 45-55°C hot air drier for two days until the water content is 10 ± 3%. 100 kg of dried mulberry leaves is mixed with 650 kg of 30% ethanol solution for ultrasound extracting for 12 hours at 40-50°C, and the mixture is filtered and decompress-concentrated. The concentrate is dissolved in a 30% ethanol solution before settling for one night at room temperature, and centrifugal-separating precipitates. Supernatant is decompress-concentrated, and dissolved in a 20% ethanol solution. The concentrate passes through a Diaion HP-20 adsorption ion resin for absorbing flavonoid, and is eluted by 30% and 50% ethanol solutions. The silica gel and Sephadex column chromatography is conducted on each fraction successively. [Reference numerals] (AA) Mulberry leaves; (BB) Extraction (650 kg, 20% ethanol solution, ultrasound extractor, 50°C, 12 hours, 2 times); (CC) Filtration; (DD) Filtrate; (EE,JJ) Decompress-concentration; (FF) Mulberry leaf ethanol extract (23 kg); (GG) Re-dissolving (100 kg, 30% ethanol solution); (HH) Settling for one night; (II) Supernatant; (KK) Mulberry leaf ethanol extract (21.2 kg); (LL) Suspension (50 kg, 20% ethanol solution); (MM) Diaion HP-20 column chromatography; (NN) 30% ethanol solution fraction; (OO) 50% ethanol solution fraction; (PP) Mulberry extract I (1.1 kg); (QQ) Mulberry extract II (0.73 kg)
Abstract:
PURPOSE: A production method of anti-liver toxicity, ant-diabetic, anti-aging, and anti-oxidative dihydroflavonol is provided to mass produce the dihydroflavonol by fermenting mulberry wine. CONSTITUTION: Mulberries are fermented and aged to obtain mulberry wine. The mulberry wine is mixed with ionized water with the same amount. The mixed solution is mixed with ethyl acetate for fractioning and separating supernatant. The ethyl acetate fraction is dissolved in a 20% ethane solution, and settled for one day to obtain supernatant. The supernatant is passed through a Diaion HP-20 ion resin for absorbing a flavonol compound, eluted by using a 50% ethanol solution, and concentrated to obtain a mulberry wine extract. ODS-A and Sephadex LH-20 column chromatography are successively performed to the mulberry wine extract.
Abstract:
본 발명은 후코이단 및 생약성분 추출물을 함께 유효성분으로 포함하는 아토피피부염 증상 개선용 크림에 관한 것으로, 상기 크림은 아토피피부염 증상을 현저히 완화시키는 효과를 나타내어, 가려움증으로 인한 긁기 횟수를 감소시키고, 혈청 IgE 농도를 감소시키며, 히스타민 농도를 감소시키고, 전체 피부층이 안정되며 세포 침윤 현상이 적으며, 비만 세포수가 감소하는 효과가 있었다.
Abstract:
PURPOSE: An ankle flexibility measuring instrument is provided to objectively measure the rotation range of an ankle for an objective and accurate diagnosis on an ankle ligament injury. CONSTITUTION: An ankle flexibility measuring instrument (100) comprises a base unit (10) which occupies the lower part of the instrument; a leg fixing unit (20) which is installed at an angle on the top of the base unit to form a space for accommodating a leg; an angle display unit (40) which includes a hollow inside and angle gradations on the surface and is attached to one side of the leg fixing unit; and an ankle rotating unit (50) which is rotatably attached to the angle display unit, displays on the surface an indicator that shows the rotation angle from a reference point, and includes a space for accommodating a foot.
Abstract:
PURPOSE: An aerial part extract of Aruncus dioicus and a novel compound isolated from the same are provided to treat leukemia or acute lymphatic leukemia including Jurkat T leukemia cells. CONSTITUTION: A pharmaceutical composition for treating leukemia contains a compound of structural formula I, II, III, IV, or V or a pharmaceutically acceptable salt thereof. The compound is isolated from an aerial part extract of Aruncus dioicus. The compound or the salt has antioxidation activity and/or cytotoxicity to Jurkat T cells.
Abstract:
PURPOSE: A user personalized meridian point stimulating method using an electroencephalogram is provided to guide brain wave of user to a normal state by stimulating the set meridian point considering the brain wave reaction characteristic of distinct user according to the current brain wave state and stimulus of user. CONSTITUTION: A user personalized meridian point stimulating apparatus using an electroencephalogram comprises the following steps. Any one operational mode of an emotion control mode, a concentration improving mode, or a health maintaining mode is entered by a user(S10). Among the preset multiple meridian points of the user's hand, a control meridian point is set to stimulate on the entered operational mode(S50). By the pre-saved method of the entered operational mode, the brain wave of user is calculated and determined on current brain wave state of user, and the control meridian point is stimulated based on the determinant(S120). [Reference numerals] (AA) Start; (BB) End; (S10) Receiving a user information input signal; (S100) Is there a channel(i) requiring emotion control?; (S110) Determining a brain wave band(j) requiring emotion control in each channel(i); (S120) Successively stimulating control meridian points corresponding to the brain wave band(j) in each channel(i); (S20) Receiving a driving mode selection signal; (S30) Driving mode is an emotion control mode?; (S40) Receiving a stimulating time setting signal; (S50) Receiving a control meridian point setting algorithm selection signal; (S60) Customized algorithm for a user?; (S70) Measuring brain waves in a stabilizing period, an acupuncture applying period, and an acupuncture removing period on each meridian point; (S80) Setting control meridian points according to brain wave bands in each channel by using the brain wave measurement values; (S85) Setting control meridian points according to brain wave bands in each channel by using prestored data; (S90) Measuring the brain wave of a user and calculating an SASI value of each channel;